IP Library Patent Application 14621930
Patent Application
App. No. 14/621,930

Multi-Purpose Bio-Material Composition

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/621,930
Abstract

The present invention relates to a multi-purpose bio-material. One preferred embodiment of the present invention generally comprises KH 2 PO 4 , a metal oxide (i.e., MgO), a calcium-containing compound, a sugar and water. Exemplary calcium containing compounds include but are not limited to tri-calcium phosphates. The invented compositions has shown excellent adhesive properties as well as surprising and significant osteoproliferative properties.

Claims (76)

1 . An osteoproliferative bio-material composition comprising KH 2 PO 4 in an amount between about 20-70 dry weight percent,

MgO in an amount between 10-50 dry weight percent,

a calcium containing compound, and

a sugar.

2 . The bio-material composition of claim 1 , further comprising water, wherein the bio-material composition is in the form of a slurry, wherein the bio-material has a controlled exothermic reaction under about 50° C. and sets in vivo.

3 . The bio-material composition of claim 2 , wherein the weight ratio of KH 2 PO 4 to MgO is between about 2:1 and 1:1.

4 . (canceled)

5 . (canceled)

6 . The bio-material composition as recited in claim 1 , wherein the calcium containing compound is Ca 10 (PO 4 ) 6 (OH) 2 .

7 . The bio-material composition as recited in claim 1 , wherein the calcium containing compound is selected from the group consisting of: α-Ca 3 (PO 4 ) 2 , β-Ca 3 (PO 4 ) 2 , Ca 10 (PO 4 ) 3 (OH) 2 , tetracalcium phosphate, amorphous calcium phosphate, bi-phasic calcium phosphate, poorly crystalline apatite, oxyapatite, octacalcium phosphate, dicalcium phosphate, dicalcium phosphate dihydrate, calcium metaphosphate, heptacalcium metaphosphate, calcium pyrophosphate and combinations thereof.

8 . The bio-material composition as recited in claim 1 , wherein the sugar is a disaccharide.

9 . The bio-material composition as recited in claim 1 , wherein the sugar is sucrose.

10 . (canceled)

11 . The bio-material composition of claim 1 , wherein:

the KH 2 PO 4 is present at between about 40 and 65 dry weight percent;

the MgO is present at between about 30 and 50 dry weight percent;

the calcium containing compound is present at between about 1 and 15 dry weight percent; and

the sugar is present at between 0.5 and 20 dry weight percent.

12 . The bio-material composition of claim 1 , wherein:

the calcium containing compound is present at between about 1 and 15 dry weight percent; and

the sugar is present at between 0.5 and 20 dry weight percent.

13 . (canceled)

14 . An osteoproliferative bio-material composition according to claim 1 , wherein the calcium containing compound is

a tri-calcium phosphate.

15 . The bio-material composition of claim 14 , wherein the weight ratio of KH 2 PO 4 to MgO is between about 2:1 and 1:1.

16 . (canceled)

17 . (canceled)

18 . (canceled)

19 . The bio-material composition of claim 14 , wherein the sugar is sucrose.

20 . (canceled)

21 . The bio-material composition of claim 14 , wherein the sugary compound is a disaccharide.

22 . The bio-material composition of claim 14 , wherein

the tri-calcium phosphate is present at between about 1 and 15 dry weight percent; and

the sugar is present at between 0.5 and 20 dry weight percent.

23 . The bio-material composition of claim 14 , wherein:

the KH 2 PO 4 is present at between about 40 and 65 dry weight percent;

the metal oxide is present at between about 30 and 50 dry weight percent;

the tri-calcium phosphate is present at between about 1 and 15 dry weight percent; and

the sugary compound is present at between 0.5 and 20 dry weight percent.

24 . The bio-material composition of claim 14 , wherein:

the KH 2 PO 4 is present at between about 40 and 50 dry weight percent;

the metal oxide is present at between about 35 and 50 dry weight percent;

the tri-calcium phosphate is present at between about 1 and 15 dry weight percent; and

the sugary compound is present at between 0.5 and 10 dry weight percent.

25 . The bio-material composition as recited in claim 14 , further comprising a sodium phosphate.

26 . An osteoproliferative bio-material composition comprising a dry phase consisting of the bio-material composition of claim 14 , and an aqueous phase.

27 . (canceled)

28 . A method for promoting hard tissue growth comprising applying a bio-material according to claim 3 to a tissue or hard tissue defect.

29 . (canceled)

30 . The method of claim 28 , wherein the hard tissue is bone.

31 . The method for promoting hard tissue growth according to claim 28 , wherein

the KH 2 PO 4 is present at between about 40 and 65 dry weight percent;

the MgO is present at between about 30 and 50 dry weight percent;

the calcium containing compound is present at between about 1 and 15 dry weight percent; and

the sugar is present at between 0.5 and 20 dry weight percent.

32 . The method for promoting hard tissue growth according to claim 28 comprising applying a bio-material to a tissue or hard tissue defect, wherein

the calcium containing compound is present at between about 1 and 15 dry weight percent; and

the sugar is present at between 0.5 and 20 dry weight percent.

33 . (canceled)

35 . A method for attaching an object to bone comprising affixing the object to the bone with the bio-material composition of claim 3 .

36 . The method of claim 35 , wherein the cementing is conducted without a fixation device.

37 . The method of claim 35 , wherein the cementing is conducted without application of growth factors.

38 . The method of claim 35 , wherein the object is an implant device.

39 . The method of claim 35 , wherein the object is bone, ligament, or tendon.

40 . A method for promoting bone growth comprising accessing a bone void and filling the bone void with a composition according to claim 3 .

41 . The method of claim 40 , wherein the filling is conducted without growth factor.

42 . The bio-material composition of claim 1 , wherein the bio-material composition is free of growth factors.

43 . The bio-material composition of claim 3 , wherein the bio-material composition is injectable through a syringe.

44 . The bio-material composition of claim 1 , wherein the slurry further comprises mono-sodium phosphate.

45 . The bio-material composition of claim 3 , wherein the composition exhibits micro and macro pores once set.

46 . A method of making an osteoproliferative bio-material composition comprising mixing,

KH 2 PO 4 in an amount between about 20-70 dry weight percent;

MgO in an amount between 10-50 dry weight percent;

a calcium containing compound; and

a sugar,

wherein the composition undergoes a controlled exothermic reaction under about 50° C. and sets in vivo.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2016
From: LALLY, THOMAS
To: BONE SOLUTIONS, INC.
Reel/Frame 038330/0778 →